Recent News
5 October 2020
London’s ‘enfant terrible’ Aim market comes of age as FTSE 100 stutters
Ivan Sedgwick, Investments Director at LGB & Co, contributed to an article in The Times on the AIM market. Read more
29 September 2020
LGB Forms an Alliance with Smith Square Partners
We are excited to announce that LGB has entered in to an alliance with Smith Square Partners ( Read more
7 September 2020
Back British biotech by improving the clinical trials process
Andrew Boyle, CEO of LGB & Co. Limited, wrote an article for Pharmiweb on how to improve the British biotech sector. Read more
1 September 2020
Is it safe to get back in the water? SME credit investments in the post-Covid world
Please join us to hear from our expert panel on how investors are viewing the market and assessing SME risk and resilience over the next 6 months and beyond. Read more
27 August 2020
COVID-19 is causing a renaissance in the UK biotech sector, we must ensure it lasts
Andrew Boyle, CEO of LGB & Co. Limited, wrote an article published in PharmaPhorum on the impact COVID-19 is having on the biotech sector in the UK. Read more
27 July 2020
Scancell raises £15m to progress three clinical programmes
On 22 July, Scancell announced a transformational £15 million fundraising that will enable the company to progress its three clinical programmes. Read more
17 July 2020
City gears up for rush of corporate takeovers sparked by Covid
Ivan Sedgwick, Investment Director, contributed to an article in the Evening Standard on a potential rush of corporate takeovers. Read more
15 July 2020
Debate: With the economy under such strain, should new fintech regulation be paused?
Andrew Boyle, CEO of LGB & Co. Limited, participated in a debate with Elisabeth Kohlbach, co-founder and chief executive at Skwire, on fintech regulations and whether they should be paused. Read more
3 July 2020
LGB joint bookrunner in £30m equity placing for AFC Energy
LGB & Co. Limited has acted as a Joint Bookrunner for AFC Energy plc (AIM: AFC), a leading provider of hydrogen power generation technologies on a £30 million equity placing. Read more
30 June 2020
How to get your business out from under the COVID-19 debt mountain
Growth businesses face owing £105bn in debt because of COVID-19. Angus Grierson, Managing Director of LGB Corporate Finance, shows the various ways you can escape the debt mountain. Read more
22 June 2020
Caveat AIMptor - buyer beware
Ivan Sedgwick, Investments Director at LGB & Co. Limited, contributed to an article for ProActive Investors on the AIM market for investors. Read more
26 May 2020